INTENT Biologics
PrivateLast Round
VC Round
Sep 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
INTENT Biologics operates in Healthcare & Life Sciences and is based in Rochester, Minnesota. Its latest recorded funding round was a VC Round in September 2025.
INTENT Biologics is a biotechnology company that develops exosome-based therapeutics for advanced wound care and immune-mediated conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INTENT Biologics Comparables
Compare INTENT Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aegle Therapeutics Corp | 79% | |
| Omnio AB | 77% | |
| BREXOGEN Inc. | 69% |
For institutional investors. Book with your work email.
INTENT Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 314% MoM.
For institutional investors. Book with your work email.
INTENT Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about INTENT Biologics's valuation, stock price, and market status.
Is INTENT Biologics a public or private company?
INTENT Biologics is a private company.
What is the current stock price of INTENT Biologics?
INTENT Biologics is a private company, so its shares have no public market price. Caplight tracks INTENT Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is INTENT Biologics worth (valuation)?
Valuation information for INTENT Biologics is not publicly available.
Can I buy INTENT Biologics stock?
INTENT Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was INTENT Biologics's last funding round?
INTENT Biologics's most recent funding round was VC Round on September 1, 2025.
Who are the main investors in INTENT Biologics?
Investor information for INTENT Biologics is not publicly disclosed.
Will INTENT Biologics IPO soon?
No public IPO plans have been announced for INTENT Biologics.
How can I track INTENT Biologics secondary market activity?
Caplight tracks bids, offers, and trades in INTENT Biologics's shares on secondary markets.